Author

M. Grimont

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:ChIP-seq· 1

Frequent Co-Authors

A. Eberhardt· 3 shared J. Caramel· 3 shared S. Dalle· 3 shared M. Plaschka· 2 shared V. Benboubker· 2 shared Y. TANG· 2 shared A.-C. Doffin· 1 shared B. Dubois· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

A. Eberhardt

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Spatial architecture of CD8+ T cells and DC subsets is critical for the response to immune checkpoint inhibitors in melanoma

E. Gobbini, M. Hubert, A.-C. Doffin, A. Eberhardt, L. Hermet, D. Li, P. Duplouye, S. Barrin, J. Berthet, V. Benboubker, M. Grimont, C. Sakref, J. Perrot, G. Tondeur, O. Harou, , J. Valladeau-Guilemond

This study examines the spatial organization of dendritic cell (DC) subsets and their interactions with CD8+ T cells in melanoma patients, finding that proximity between cDC1 and CD8+ T cells correlates with response to immune checkpoint inhibitors.

bioRxiv · Feb 6, 2024 · PreprintCancer Biology

ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions

S. Durand, Y. TANG, R. M. Pommier, V. Benboubker, M. Grimont, F. Boivin, L. Barbollat, E. Cumunel, F. Dupeuble, A. Eberhardt, M. Plaschka, S. Dalle, J. CARAMEL

This study identifies ZEB1 as a key transcriptional regulator driving melanoma cell state transitions by modulating lineage-specific programs.

bioRxiv · Feb 10, 2023Cancer Biology

An in vivo avian model of human melanoma to perform rapid and robust preclinical studies

L. Jarrosson, S. Dalle, C. Costechareyre, Y. Tang, M. Grimont, M. Plaschka, M. Lacourrege, R. Teinturier, M. Le Bouar, D. Maucort-Boulch, A. Eberhardt, V. Castellani, J. Caramel, C. Delloye-Bourgeois

This paper develops an avian xenograft model to rapidly study melanoma drug responses and resistance mechanisms in vivo.

bioRxiv · Oct 12, 2022 · PreprintCancer Biology